Literature DB >> 31762145

Structural and functional characterization of three Type B and C chloramphenicol acetyltransferases from Vibrio species.

Ashley Alcala1, Guadalupe Ramirez1, Allan Solis1, Youngchang Kim2,3, Kemin Tan2,3, Oscar Luna1, Karen Nguyen1, Daniel Vazquez1, Michael Ward1, Min Zhou2,3, Rory Mulligan2,3, Natalia Maltseva2,3, Misty L Kuhn1.   

Abstract

Chloramphenicol acetyltransferases (CATs) were among the first antibiotic resistance enzymes identified and have long been studied as model enzymes for examining plasmid-mediated antibiotic resistance. These enzymes acetylate the antibiotic chloramphenicol, which renders it incapable of inhibiting bacterial protein synthesis. CATs can be classified into different types: Type A CATs are known to be important for antibiotic resistance to chloramphenicol and fusidic acid. Type B CATs are often called xenobiotic acetyltransferases and adopt a similar structural fold to streptogramin acetyltransferases, which are known to be critical for streptogramin antibiotic resistance. Type C CATs have recently been identified and can also acetylate chloramphenicol, but their roles in antibiotic resistance are largely unknown. Here, we structurally and kinetically characterized three Vibrio CAT proteins from a nonpathogenic species (Aliivibrio fisheri) and two important human pathogens (Vibrio cholerae and Vibrio vulnificus). We found all three proteins, including one in a superintegron (V. cholerae), acetylated chloramphenicol, but did not acetylate aminoglycosides or dalfopristin. We also determined the 3D crystal structures of these CATs alone and in complex with crystal violet and taurocholate. These compounds are known inhibitors of Type A CATs, but have not been explored in Type B and Type C CATs. Based on sequence, structure, and kinetic analysis, we concluded that the V. cholerae and V. vulnificus CATs belong to the Type B class and the A. fisheri CAT belongs to the Type C class. Ultimately, our results provide a framework for studying the evolution of antibiotic resistance gene acquisition and chloramphenicol acetylation in Vibrio and other species.
© 2019 The Protein Society.

Entities:  

Keywords:  zzm321990Aliivibrio fischeri; Vibrio cholerae; Vibrio vulnificus; antibiotic resistance; biochemical education; chloramphenicol acetyltransferase; functional characterization; gene annotation; integron; xenobiotic acetyltransferase

Year:  2019        PMID: 31762145      PMCID: PMC7020993          DOI: 10.1002/pro.3793

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  41 in total

1.  Controlled intracellular processing of fusion proteins by TEV protease.

Authors:  R B Kapust; D S Waugh
Journal:  Protein Expr Purif       Date:  2000-07       Impact factor: 1.650

2.  Double trouble-Buffer selection and His-tag presence may be responsible for nonreproducibility of biomedical experiments.

Authors:  Karolina A Majorek; Misty L Kuhn; Maksymilian Chruszcz; Wayne F Anderson; Wladek Minor
Journal:  Protein Sci       Date:  2014-07-30       Impact factor: 6.725

Review 3.  Molecular basis of bacterial resistance to chloramphenicol and florfenicol.

Authors:  Stefan Schwarz; Corinna Kehrenberg; Benoît Doublet; Axel Cloeckaert
Journal:  FEMS Microbiol Rev       Date:  2004-11       Impact factor: 16.408

4.  A novel family of intrinsic chloramphenicol acetyltransferase CATC in Vibrio parahaemolyticus: Naturally occurring variants reveal diverse resistance levels against chloramphenicol.

Authors:  Gang Zhang; Kaiwen Sun; Guomin Ai; Jianjuan Li; Na Tang; Yuqin Song; Chao Wang; Jie Feng
Journal:  Int J Antimicrob Agents       Date:  2019-03-14       Impact factor: 5.283

5.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

Review 6.  Chloramphenicol acetyltransferase: enzymology and molecular biology.

Authors:  W V Shaw
Journal:  CRC Crit Rev Biochem       Date:  1983

7.  Resistance to fusidic acid in Escherichia coli mediated by the type I variant of chloramphenicol acetyltransferase. A plasmid-encoded mechanism involving antibiotic binding.

Authors:  A D Bennett; W V Shaw
Journal:  Biochem J       Date:  1983-10-01       Impact factor: 3.857

8.  The Buccaneer software for automated model building. 1. Tracing protein chains.

Authors:  Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2006-08-19

9.  REFMAC5 for the refinement of macromolecular crystal structures.

Authors:  Garib N Murshudov; Pavol Skubák; Andrey A Lebedev; Navraj S Pannu; Roberto A Steiner; Robert A Nicholls; Martyn D Winn; Fei Long; Alexei A Vagin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

10.  A high-enrollment course-based undergraduate research experience improves student conceptions of scientific thinking and ability to interpret data.

Authors:  Sara E Brownell; Daria S Hekmat-Scafe; Veena Singla; Patricia Chandler Seawell; Jamie F Conklin Imam; Sarah L Eddy; Tim Stearns; Martha S Cyert
Journal:  CBE Life Sci Educ       Date:  2015-06-01       Impact factor: 3.325

View more
  2 in total

1.  Structural characterization of a Type B chloramphenicol acetyltransferase from the emerging pathogen Elizabethkingia anophelis NUHP1.

Authors:  Seyed Mohammad Ghafoori; Alyssa M Robles; Angelika M Arada; Paniz Shirmast; David M Dranow; Stephen J Mayclin; Donald D Lorimer; Peter J Myler; Thomas E Edwards; Misty L Kuhn; Jade K Forwood
Journal:  Sci Rep       Date:  2021-05-04       Impact factor: 4.379

Review 2.  Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies.

Authors:  Nayanika Chakraborty; Diksha Jha; Indrajit Roy; Pradeep Kumar; Shailendra Singh Gaurav; Kalisvar Marimuthu; Oon-Tek Ng; Rajamani Lakshminarayanan; Navin Kumar Verma; Hemant K Gautam
Journal:  J Nanobiotechnology       Date:  2022-08-12       Impact factor: 9.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.